Physician profile
Alison Smith
NPI 1962619304
$1,616.27
in general payments reported to CMS, 2019-2025
18 companies · $338 in 2025
The $338 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $75.52 · 2021: $212 · 2022: $103 · 2023: $485 · 2024: $225 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,047.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $322.01 | 2019-2024 | Clareon |
| Amgen INC. | $321.55 | 2024-2025 | Tepezza |
| Horizon Therapeutics Plc | $138.55 | 2022-2023 | Tepezza |
| Abbott Laboratories | $130.02 | 2023 | Cardiomems |
| Mallinckrodt Hospital Products INC. | $121.87 | 2023 | Acthar |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $121.29 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $86.64 | 2022-2025 | Infuse, Btod, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $52.38 | 2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $46.22 | 2020-2022 | |
| Abbvie INC. | $41.10 | 2024-2025 | |
| Glaukos Corporation | $40.04 | 2020-2022 | |
| Rayner Intraocular Lenses Limited | $37.54 | 2023 | Rayone Aspheric, Rayone Emv, Omidria |
| Harrow Eye, LLC | $33.76 | 2025 | Iheezo |
| Dompe US, INC. | $33.47 | 2019-2023 | Oxervate |
| Thea Pharma INC. | $25.55 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $25.29 | 2019 | |
| Biotissue Holdings INC. | $24.51 | 2022 | |
| Coopervision INC. | $14.48 | 2023 | Synergeyes Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.